BMEWS
 
 

is a drug to cure baldness really on the way?

Yeah well, way too late for me.  That’s one of so many damn problems one encounters in my generation. These things will one day come to pass, but too late for us.  Hey, I confess it. I HATE being bald on top.  There were some guys that didn’t actually look all that bad minus hair. Telly Savalas is one and another late actor was Yul Brynner. I didn’t think they looked bad at all.  But I know I do and that’s the truth.  At least as I see it.
So anyway I happened to spot this and thought I’d share it. Maybe some of you lucky younger guys who’ve lost it will have something like this in your future. 

How eye drops could stop you going bald - thanks to an unusual side effect

Glaucoma eye drops found to stimulate eyelash growth
Early clinical trials suggest drug could help follicles to produce a third more scalp hair than usual

By Jenny Hope

A drug that helps to stop blindness could soon be used to combat baldness.

Lumigan eye-drops are an established treatment for glaucoma, a condition caused by excess fluid in the eye.

But it has a side-effect that has excited scientists – it can stimulate the growth of eyelashes.

Now research suggests the active ingredient in Lumigan, called bimatoprost, could have the same effect on the scalp.

Preliminary trials are underway to see whether bimatoprost can reverse hair loss in both men and women.

If successful, the drug could get a new lease of life as a baldness treatment. Lead scientist Professor Valerie Randall, from the University of Bradford, said: ‘Bimatoprost is known to stimulate eyelash growth and is already used clinically for this purpose.

‘We wanted to see whether it would have the same effect on scalp hair, as the two types of follicle are very different.

‘Our findings show that bimatoprost does stimulate growth in human scalp hair follicles and therefore could offer a new approach for treating hair loss disorders.’

Findings from the laboratory research appear in The FASEB Journal, published by the Federation of American Societies for Experimental Biology. The drug was tested on living scalp tissue obtained from volunteer donors undergoing cosmetic surgery.

Follicles treated with bimatoprost grew a third more hair than untreated samples in just nine days.

Scalp follicles were found to contain exactly the same molecular receptors responsive to bimatoprost as eyelash follicles.

‘This means that – so long as the drug can be applied in such a way that it can reach the follicle – it should stimulate hair growth in patients,’ said Professor Randall.

Results from the next phase of the clinical trials currently taking place in the United States and Germany should be available before the end of the year.

They involve 220 men with male pattern baldness and 172 women with female pattern baldness.

Participants are undergoing six months of treatment with either a solution of bimatoprost, applied to the scalp, or an inactive placebo (dummy treatment).

A comparison with the well-known baldness treatment minoxidil is also being assessed.

Professor Randall acts as a consultant to Allergan Inc which manufactures Lumigan.

The well-known effect of Lumigan on eyelashes also comes with its own side-effect, it causes darkening of eye colour and eyelid skin, which may not be reversible.

It is not known if this side-effect will occur on the scalp.

SOURCE



Posted by peiper    United Kingdom   on 11/02/2012 at 05:24 PM   
 
Commenting is not available in this weblog entry.

Next entry: the deep divisions in American society

Previous entry: eye candy for a cold friday night

<< BMEWS Main Page >>